Tumor classification of gastrointestinal liver metastases using CT-based radiomics and deep learning.
Deep learning
Gastrointestinal
Machine learning
Metastases
Radiomics
Journal
Cancer imaging : the official publication of the International Cancer Imaging Society
ISSN: 1470-7330
Titre abrégé: Cancer Imaging
Pays: England
ID NLM: 101172931
Informations de publication
Date de publication:
05 Oct 2023
05 Oct 2023
Historique:
received:
14
06
2022
accepted:
17
09
2023
medline:
26
10
2023
pubmed:
6
10
2023
entrez:
5
10
2023
Statut:
epublish
Résumé
The goal of this study is to demonstrate the performance of radiomics and CNN-based classifiers in determining the primary origin of gastrointestinal liver metastases for visually indistinguishable lesions. In this retrospective, IRB-approved study, 31 pancreatic cancer patients with 861 lesions (median age [IQR]: 65.39 [56.87, 75.08], 48.4% male) and 47 colorectal cancer patients with 435 lesions (median age [IQR]: 65.79 [56.99, 74.62], 63.8% male) were enrolled. A pretrained nnU-Net performed automated segmentation of 1296 liver lesions. Radiomics features for each lesion were extracted using pyradiomics. The performance of several radiomics-based machine-learning classifiers was investigated for the lesions and compared to an image-based deep-learning approach using a DenseNet-121. The performance was evaluated by AUC/ROC analysis. The radiomics-based K-nearest neighbor classifier showed the best performance on an independent test set with AUC values of 0.87 and an accuracy of 0.67. In comparison, the image-based DenseNet-121-classifier reached an AUC of 0.80 and an accuracy of 0.83. CT-based radiomics and deep learning can distinguish the etiology of liver metastases from gastrointestinal primary tumors. Compared to deep learning, radiomics based models showed a varying generalizability in distinguishing liver metastases from colorectal cancer and pancreatic adenocarcinoma.
Identifiants
pubmed: 37798797
doi: 10.1186/s40644-023-00612-4
pii: 10.1186/s40644-023-00612-4
pmc: PMC10557291
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
95Informations de copyright
© 2023. International Cancer Imaging Society (ICIS).
Références
Cancers (Basel). 2021 Nov 16;13(22):
pubmed: 34830885
Cancer Imaging. 2019 Feb 27;19(1):11
pubmed: 30813956
Radiology. 2016 Feb;278(2):563-77
pubmed: 26579733
Magn Reson Imaging. 2012 Nov;30(9):1323-41
pubmed: 22770690
Diagnostics (Basel). 2022 Dec 26;13(1):
pubmed: 36611358
Nat Commun. 2020 Feb 5;11(1):728
pubmed: 32024849
Eur Radiol. 2018 Dec;28(12):5284-5292
pubmed: 29882070
Radiology. 2018 Aug;288(2):318-328
pubmed: 29944078
Eur Radiol. 2021 Feb;31(2):834-846
pubmed: 32851450
Cancers (Basel). 2022 Mar 24;14(7):
pubmed: 35406418
Cancer Res. 2017 Nov 1;77(21):e104-e107
pubmed: 29092951
Front Oncol. 2022 Jan 07;11:689509
pubmed: 35070948
Nat Rev Cancer. 2019 Dec;19(12):686-697
pubmed: 31519982
Cancer Cell. 2018 Jul 9;34(1):148-162.e7
pubmed: 29990497
Front Oncol. 2021 Jan 29;10:581210
pubmed: 33585197
Sci Rep. 2021 May 11;11(1):9984
pubmed: 33976268
Nat Med. 2021 Feb;27(2):212-224
pubmed: 33574607
Neuroimage Clin. 2016 Nov 20;13:264-270
pubmed: 28018853
Radiol Imaging Cancer. 2021 Apr;3(4):e200157
pubmed: 34114913
PLoS One. 2014 May 07;9(5):e96873
pubmed: 24804720
Nat Rev Cancer. 2018 Aug;18(8):500-510
pubmed: 29777175
Cancers (Basel). 2022 Jan 29;14(3):
pubmed: 35158980
Cancers (Basel). 2021 Jun 20;13(12):
pubmed: 34203103
Curr Oncol Rep. 2019 Jun 25;21(8):70
pubmed: 31240403
Nat Rev Dis Primers. 2021 Apr 15;7(1):27
pubmed: 33859205
Nat Methods. 2021 Feb;18(2):203-211
pubmed: 33288961
Cancer Epidemiol. 2020 Aug;67:101760
pubmed: 32562887